Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive

P Boekstegers1, P Steinbigler, A Molnar

  • 1Internal Medicine I, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany. boekstegers@med1.med.uni-muenchen.de

Insights

Pressure-guided nonsurgical myocardial reduction (NSMR) effectively reduces left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy (HOCM) patients. This safe procedure improves symptoms and quality of life by inducing small septal infarctions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by left ventricular outflow tract (LVOT) obstruction.
  • Nonsurgical myocardial reduction (NSMR) aims to alleviate LVOT obstruction and improve patient symptoms.
  • Previous NSMR studies show variable infarct sizes, impacting outcomes.

Purpose of the Study:

  • To evaluate the safety and efficacy of pressure-guided NSMR in HOCM patients.
  • To assess the impact of inducing small septal infarctions on LVOT obstruction and symptoms.

Main Methods:

  • Fifty HOCM patients underwent pressure-guided NSMR.
  • LVOT gradients were measured invasively pre-intervention and at 4-6 and 12-18 months post-NSMR.
  • Patient-reported outcomes (NYHA class, quality of life) and exercise capacity were assessed.

Main Results:

  • Small septal infarctions led to a sustained reduction in LVOT gradients from 80 mmHg to 17-18 mmHg (p < 0.001).
  • NSMR was associated with decreased LV hypertrophy and improved exercise capacity.
  • Quality of life significantly improved post-procedure.

Conclusions:

  • Pressure-guided NSMR with small septal infarctions effectively reduces LVOT obstruction and improves HOCM symptoms.
  • Minimizing infarct size may reduce complication rates, such as complete heart block requiring permanent pacemaker implantation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...